BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28817833)

  • 21. PPy@Fe
    Yu Z; Tong S; Wang C; Wu Z; Ye Y; Wang S; Jiang K
    Front Bioeng Biotechnol; 2022; 10():1001994. PubMed ID: 36177184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell competition constitutes a barrier for interspecies chimerism.
    Zheng C; Hu Y; Sakurai M; Pinzon-Arteaga CA; Li J; Wei Y; Okamura D; Ravaux B; Barlow HR; Yu L; Sun HX; Chen EH; Gu Y; Wu J
    Nature; 2021 Apr; 592(7853):272-276. PubMed ID: 33508854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COMMD10 Is Essential for Neural Plate Development during Embryogenesis.
    Phan KP; Pelargos P; Tsytsykova AV; Tsitsikov EN; Wiley G; Li C; Bebak M; Dunn IF
    J Dev Biol; 2023 Mar; 11(1):. PubMed ID: 36976102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum: PPy@Fe
    Yu Z; Tong S; Wang C; Wu Z; Ye Y; Wang S; Jiang K
    Front Bioeng Biotechnol; 2023; 11():1148674. PubMed ID: 37829563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.
    Song S; Wu HG; Lee CG; Keum KC; Kim MS; Ahn YC; Oh D; Park HJ; Lee SW; Park G; Moon SH; Cho KH; Kim YS; Won Y; Oh YT; Kim WT; Jeong JU
    BMC Cancer; 2017 Aug; 17(1):598. PubMed ID: 28854890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human.
    Fan Y; Zhang L; Sun Y; Yang M; Wang X; Wu X; Huang W; Chen L; Pan S; Guan J
    Cancer Gene Ther; 2020 Apr; 27(3-4):216-225. PubMed ID: 30787448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and modulation mechanisms of COMMD6 in human tumours based on expression profiling and comprehensive bioinformatics analysis.
    Yang M; Huang W; Sun Y; Liang H; Chen M; Wu X; Wang X; Zhang L; Cheng X; Fan Y; Pan H; Chen L; Guan J
    Br J Cancer; 2019 Oct; 121(8):699-709. PubMed ID: 31523056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COMMD1, a multi-potent intracellular protein involved in copper homeostasis, protein trafficking, inflammation, and cancer.
    Weiskirchen R; Penning LC
    J Trace Elem Med Biol; 2021 May; 65():126712. PubMed ID: 33482423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway.
    Cui Y; Wu X; Lin C; Zhang X; Ye L; Ren L; Chen M; Yang M; Li Y; Li M; Li J; Guan J; Song L
    Oncogene; 2019 Jul; 38(27):5516-5529. PubMed ID: 30936461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COMMD10 inhibits tumor progression and induces apoptosis by blocking NF-κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma.
    Yang M; Wu X; Li L; Li S; Li N; Mao M; Pan S; Du R; Wang X; Chen M; Xiao N; Zhu X; He G; Zhang L; Huang W; Pan H; Deng L; Chen L; Liang L; Guan J
    Clin Transl Med; 2021 May; 11(5):e403. PubMed ID: 34047468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-κB pathway.
    Huang W; Zhang L; Yang M; Wu X; Wang X; Huang W; Yuan L; Pan H; Wang Y; Wang Z; Wu Y; Huang J; Liang H; Li S; Liao L; Liu L; Guan J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):87. PubMed ID: 33648530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding Gastric Cancer: Machine Learning Insights Into the Significance of COMMDs Family in Immunotherapy and Diagnosis.
    Wan R; Pan L; Wang Q; Shen G; Guo R; Qin Y; Huang X; Wang R; Fan X
    J Cancer; 2024; 15(11):3580-3595. PubMed ID: 38817875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive analysis of COMMD10 as a novel prognostic biomarker for gastric cancer.
    Zhao W; Lin J; Cheng S; Li H; Shu Y; Xu C
    PeerJ; 2023; 11():e14645. PubMed ID: 36919165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COMMD proteins function and their regulating roles in tumors.
    You G; Zhou C; Wang L; Liu Z; Fang H; Yao X; Zhang X
    Front Oncol; 2023; 13():1067234. PubMed ID: 36776284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia.
    Xie Y; Lin H; Wei W; Kong Y; Fang Q; Chen E; Liu J; Li M
    Sci Rep; 2022 Nov; 12(1):18757. PubMed ID: 36335129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COMMD3 Expression Affects Angiogenesis through the HIF1
    Zhu T; Peng X; Cheng Z; Gong X; Xing D; Cheng W; Zhang M
    Oxid Med Cell Longev; 2022; 2022():1655502. PubMed ID: 36092163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COMMD2 Upregulation Mediated by an ncRNA Axis Correlates With an Unfavorable Prognosis and Tumor Immune Infiltration in Liver Hepatocellular Carcinoma.
    Fang W; Gan Y; Zhang L; Xiong J
    Front Oncol; 2022; 12():853026. PubMed ID: 35574298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the Association between COMMD3 Expression and the Prognosis of Hepatocellular Carcinoma.
    Cheng W; Cheng Z; Zhang C; Weng L; Xing D; Zhang M
    J Cancer; 2022; 13(6):1871-1881. PubMed ID: 35399735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FMNL2 suppresses cell migration and invasion of breast cancer: a reduction of cytoplasmic p27 via RhoA/LIMK/Cofilin pathway.
    Jiao X; Wang B; Yang L; Zhao Q; Zhang M; Liu X; Zhou C; Wang R; Chen H; Wang J; Ren Y; Liu P
    Cell Death Discov; 2022 Apr; 8(1):155. PubMed ID: 35379791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.